These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 5125054

  • 1. [Long-term effects of amantadine in striatal syndromes].
    Rovetta P.
    Minerva Med; 1971 Oct 31; 62(82):3965-7. PubMed ID: 5125054
    [No Abstract] [Full Text] [Related]

  • 2. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM, Baroni A.
    Minerva Med; 1971 Oct 31; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K.
    Schweiz Med Wochenschr; 1971 Dec 04; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract] [Full Text] [Related]

  • 4. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S, Nagaswami R.
    Dis Nerv Syst; 1973 Dec 04; 34(5):253-8. PubMed ID: 4782280
    [No Abstract] [Full Text] [Related]

  • 5. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM, Zlydnikov DM, Mazhinskaia VP, Lebedeva VK, Zakharova NG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Dec 04; 73(4):530-4. PubMed ID: 4705408
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F, Baroni A, Roveyaz L.
    Sist Nerv; 1970 Dec 04; 22(2):74-81. PubMed ID: 5504560
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Catecholamine excretion and treatment of parkinsonism with midantan].
    Kandel' EI, Iadgarov IS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep 04; 76(9):1323-6. PubMed ID: 1015136
    [No Abstract] [Full Text] [Related]

  • 11. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A, Nardini M, Sorgona F.
    Sist Nerv; 1970 Sep 04; 22(5):273-85. PubMed ID: 5514245
    [No Abstract] [Full Text] [Related]

  • 12. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
    Evtushenko SK.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec 04; 76(12):1797-1802. PubMed ID: 1015115
    [Abstract] [Full Text] [Related]

  • 13. [On the action of amantadine in postencephalitic parkinsonism].
    Pennacchietti M, Aletto PM.
    Minerva Med; 1971 Oct 31; 62(82):3960-2. PubMed ID: 5125052
    [No Abstract] [Full Text] [Related]

  • 14. [Effects of amantadine on the state of consciousness in diffuse cerebral psychosyndromes caused by vascular disorders].
    Vitetta M.
    Minerva Med; 1971 Oct 31; 62(82):3984-6. PubMed ID: 5125059
    [No Abstract] [Full Text] [Related]

  • 15. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome].
    Kadykov AS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Oct 31; 76(2):174-8. PubMed ID: 944514
    [Abstract] [Full Text] [Related]

  • 16. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM, Schmitt PP.
    Curr Ther Res Clin Exp; 1973 Aug 31; 15(8):552-8. PubMed ID: 4200529
    [No Abstract] [Full Text] [Related]

  • 17. [Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results].
    Bergamini L, Bonzanino O, Brignolio F, Fabiani A, Fariello R, Mombelli AM, Mutani R, Pisani W, Postir A, Riccio A, Sabbatini F, Sandigliano G, Schiffer D.
    Riv Patol Nerv Ment; 1969 Oct 31; 90(5):329-49. PubMed ID: 5406104
    [No Abstract] [Full Text] [Related]

  • 18. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F, Grünberger J, Schubert H.
    Nervenarzt; 1973 Aug 31; 44(8):428-33. PubMed ID: 4733895
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.